Advancing Continous Concentration with Patented Cadence Single-Pass TFF
Single-pass tangential flow filtration (SPTFF) technology from Pall Life Science is a versatile concentration approach for biotech, vaccine and plasma industry applications. Patented Cadence™ SPTFF technology offers a total solution for inline volume reduction and/or concentration, in-process dilution/de-salting, high concentration formulations, and processing of fragile molecules, crucially enabling integrated, streamlined and continuous bioprocessing initiatives.

Moderator


Kevin Marino
Global Product Manager, Continuous Filtration
Pall Biotech

Speakers


Jon Petrone
Senior Director, SLS Bioprocess Integration Team
Pall Biotech
Advancing Continous Concentration with Patented Cadence Single-Pass TFF
See how you can save up to 30% on the cost of goods per batch
Biotech | Pall Corporation webinar series
In 2019 Swissfillon were inspected and approved by the FDA to supply drug products into the USA, following on from EU approval in 2018. This young fill finish CMO was started in Switzerland in 2013 and built a state-of-the-art cGMP production facility from the ground up.
Swissfillon recognized early on that single-use systems met their requirements for multi-product manufacturing and would help their clients get their drugs to market faster.
During this case-study webinar, participants will learn:
- How working in partnership with a supplier can be part of a QbD approach to minimize risk
- Strategies & design improvements for single-use systems to reduce risk in the process
- How a shadowboard can be used to make single-use system leak tests, PUPSIT and the filtration process fast, safe and simple